BioAtla BCAB
OTC BCAB
$1.45 +0.12 (+9.02%)
As of: Oct 21, 2026 · 12:24 PM EDT

BioAtla (BCAB) Invested Capital (2020 - 2021)

Updated

BioAtla (BCAB) recorded Invested Capital of $210.82 million in Q4 2021, up 0.1% from $210.66 million a year earlier but down 8.6% from the prior quarter.

Analysis

BioAtla (BCAB) Invested Capital (2020 - 2021) Analysis & Trends

Starting with Q4 2020, BioAtla's Invested Capital history includes 5 quarters.

  • Across earlier years, Invested Capital came in at $210.66 million in FY2020.
  • Quarterly Invested Capital has ranged from $178.71 million in Q2 2021 to $230.65 million in Q3 2021 over the past five years.
  • Per Business Quant, the preceding three quarters came in at $230.65 million (Q3 2021), $178.71 million (Q2 2021) and $196.6 million (Q1 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 88.79 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 134.01 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 64.89 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 95.89 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 51.53 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 82.72 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 68.99 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 38.08 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 148.69 Bn
10 BioAtla 2.41 Mn -16.54 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 210.82 Mn
Sep 30, 2021 230.65 Mn
Jun 30, 2021 178.71 Mn
Mar 31, 2021 196.60 Mn
Dec 31, 2020 210.66 Mn
API Access

BioAtla Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=BCAB&period=max&api_key=YOUR_API_KEY